BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33474568)

  • 1. Impact of pasireotide on postoperative pancreatic fistulas following distal resections.
    Vuorela T; Mustonen H; Kokkola A; Haglund C; Seppanen H
    Langenbecks Arch Surg; 2021 May; 406(3):735-742. PubMed ID: 33474568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pasireotide is not effective in reducing the development of postoperative pancreatic fistula.
    Young S; Sung ML; Lee JA; DiFronzo LA; O'Connor VV
    HPB (Oxford); 2018 Sep; 20(9):834-840. PubMed ID: 30060910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for postoperative pancreatic fistula in the Era of pasireotide.
    Potter KC; Sutton TL; O'Grady J; Gilbert EW; Pommier R; Mayo SC; Sheppard BC
    Am J Surg; 2022 Aug; 224(2):733-736. PubMed ID: 35221100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pasireotide administration after pancreaticoduodenectomy may decrease clinically relevant postoperative pancreatic fistula in high-risk patients with small pancreatic ducts, soft pancreatic parenchyma and cystic or neuroendocrine neoplasia.
    Vuorela T; Mustonen H; Kokkola A; Haglund C; Seppänen H
    Pancreatology; 2020 Jun; 20(4):757-761. PubMed ID: 32307251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Pasireotide for Prevention of Postoperative Pancreatic Fistula in Pancreatic Surgery: a Systematic Review and Meta-analysis.
    Liu X; Pausch T; Probst P; Cui J; Wei J; Hackert T; Miao Y
    J Gastrointest Surg; 2020 Jun; 24(6):1421-1429. PubMed ID: 32207077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness comparison of prophylactic octreotide and pasireotide for prevention of fistula after pancreatic surgery.
    Welsch T; Müssle B; Distler M; Knoth H; Weitz J; Häckl D
    Langenbecks Arch Surg; 2016 Nov; 401(7):1027-1035. PubMed ID: 27233242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide and postoperative pancreatic fistula after pancreaticoduodenectomy: What we know so far? A narrative review.
    Tilak M; Tewari M; Shukla HS
    Indian J Cancer; 2023; 60(2):152-159. PubMed ID: 37530235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Perioperative Administration of Pasireotide is More Cost-Effective Than Routine Administration for Pancreatic Fistula Prophylaxis.
    Denbo JW; Slack RS; Bruno M; Cloyd JM; Prakash L; Fleming JB; Kim MP; Aloia TA; Vauthey JN; Lee JE; Katz MH
    J Gastrointest Surg; 2017 Apr; 21(4):636-646. PubMed ID: 28050766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pasireotide for postoperative pancreatic fistula.
    Allen PJ; Gönen M; Brennan MF; Bucknor AA; Robinson LM; Pappas MM; Carlucci KE; D'Angelica MI; DeMatteo RP; Kingham TP; Fong Y; Jarnagin WR
    N Engl J Med; 2014 May; 370(21):2014-22. PubMed ID: 24849084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-stratified analysis of pasireotide for patients undergoing pancreatectomy.
    Peng JS; Joyce D; Brady M; Groman A; Attwood K; Kuvshinoff B; Hochwald SN; Kukar M
    J Surg Oncol; 2020 Aug; 122(2):195-203. PubMed ID: 32474957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pasireotide does not prevent postoperative pancreatic fistula: a prospective study.
    Elliott IA; Dann AM; Ghukasyan R; Damato L; Girgis MD; King JC; Hines OJ; Reber HA; Donahue TR
    HPB (Oxford); 2018 May; 20(5):418-422. PubMed ID: 29398424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do somatostatin-analogues have the same impact on postoperative morbidity and pancreatic fistula in patients after pancreaticoduodenectomy and distal pancreatectomy? - A systematic review with meta-analysis of randomized-controlled trials.
    Schorn S; Vogel T; Demir IE; Demir E; Safak O; Friess H; Ceyhan GO
    Pancreatology; 2020 Dec; 20(8):1770-1778. PubMed ID: 33121847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-Analysis on the Effect of Pasireotide for Prevention of Postoperative Pancreatic Fistula.
    Dalton EC; Johns MS; Rhodes L; Merritt WT; Petrelli NJ; Tiesi GJ
    Am Surg; 2020 Dec; 86(12):1728-1735. PubMed ID: 32870029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications.
    Marchegiani G; Andrianello S; Nessi C; Sandini M; Maggino L; Malleo G; Paiella S; Polati E; Bassi C; Salvia R
    Ann Surg Oncol; 2018 Mar; 25(3):626-637. PubMed ID: 29214453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High risk pathogens and risk factors for postoperative pancreatic fistula after pancreatectomy; a retrospective case-controlled study.
    Abe K; Kitago M; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Yokose T; Endo Y; Kitagawa Y
    Int J Surg; 2020 Oct; 82():136-142. PubMed ID: 32861892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Evaluation of Pasireotide in Patients Undergoing Pancreaticoduodenectomy: The Washington University Experience.
    Dominguez-Rosado I; Fields RC; Woolsey CA; Williams G; Horwedel TA; Rose JB; Hammill CW; Doyle MB; Chapman WC; Strasberg SM; Hawkins WG; Sanford DE
    J Am Coll Surg; 2018 Feb; 226(2):147-154.e1. PubMed ID: 29133263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative pancreatic fistulas are not equivalent after proximal, distal, and central pancreatectomy.
    Pratt W; Maithel SK; Vanounou T; Callery MP; Vollmer CM
    J Gastrointest Surg; 2006 Nov; 10(9):1264-78; discussion 1278-9. PubMed ID: 17114013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial.
    Ma LW; Dominguez-Rosado I; Gennarelli RL; Bach PB; Gonen M; D'Angelica MI; DeMatteo RP; Kingham TP; Brennan MF; Jarnagin WR; Allen PJ
    Ann Surg; 2017 Jan; 265(1):11-16. PubMed ID: 27429029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin analogues and the risk of post-operative pancreatic fistulas after pancreatic resection - A systematic review & meta-analysis.
    Li T; D'Cruz RT; Lim SY; Shelat VG
    Pancreatology; 2020 Mar; 20(2):158-168. PubMed ID: 31980352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review and meta-analysis of somatostatin analogues in the prevention of postoperative complication after pancreaticoduodenectomy.
    Jin K; Zhou H; Zhang J; Wang W; Sun Y; Ruan C; Hu Z; Wang Y
    Dig Surg; 2015; 32(3):196-207. PubMed ID: 25872003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.